We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FG:NYSEF&G Annuities & Life, Inc. Analysis

Data as of 2026-04-02 - not real-time

$26.05

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

F&G Annuities & Life is trading at $26.05, which sits above its 20‑day SMA but still below the 200‑day SMA, indicating a short‑term bounce within a longer‑term downtrend. The 20‑day SMA (23.5) has crossed above the 50‑day SMA (25.5) and the MACD histogram is positive, suggesting underlying bullish momentum, yet the technical trend is flagged as bearish and the RSI at 61 points to limited upside before overbought conditions. The stock is supported at roughly $20.57 and faces resistance near $26.25, while volatility over the past 30 days is unusually high at over 50%, implying sizable price swings. On the fundamentals side, the forward P/E of about 4 is dramatically below the sector average, the trailing P/E of 13.9 is also under the industry mean, and the DCF‑derived upside is estimated at roughly 13%, all pointing to an undervalued position. The company posted a revenue growth of 13% YoY, maintains a solid dividend yield of 3.9% with a payout ratio under 50%, and its balance sheet shows cash exceeding debt, supporting dividend sustainability. However, the latest quarter missed earnings expectations by more than 30%, which has dampened short‑term sentiment.
Overall, the blend of attractive valuation, strong cash generation, and a resilient dividend makes FG a compelling buy for medium‑ to long‑term horizons, while the near‑term price action and earnings miss suggest a cautious hold stance in the immediate term.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • price hovering near resistance with a bearish longer‑term trend
  • recent earnings miss of -32% versus consensus
  • stable dividend yield providing downside cushion

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • valuation metrics indicating ~13% upside
  • robust revenue growth and expanding earnings outlook
  • high, sustainable dividend yield

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • cash balance exceeding debt, enhancing financial resilience
  • forward earnings expectations driven by strong product demand
  • consistent dividend policy and attractive price‑to‑book ratio

Key Metrics & Analysis

Financial Health

Revenue Growth13.20%
Profit Margin4.62%
P/E Ratio13.9
ROE6.03%
ROA0.33%
Debt/Equity45.98
P/B Ratio0.7
Op. Cash Flow$4.7B
Free Cash Flow$2.8B
Industry P/E16.6

Technical Analysis

TrendBearish
RSI61.1
Support$20.57
Resistance$26.25
MA 20$23.54
MA 50$25.46
MA 200$30.22
MACDBullish
VolumeStable
Fear & Greed Index78.8

Valuation

Fair Value$479.93
Target Price$29.50
Upside/Downside13.24%
GradeUndervalued
TypeBlend
Dividend Yield3.88%

Risk Assessment

Beta0.76
Volatility54.74%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.